๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-07-27

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis (NCT06642610)

CGM Dynamic Index (CDI) for Predicting Prediabetes in People With Cystic Fibrosis

๐ŸŸข Recruiting Observational / Diagnostic โš™๏ธ Medical Device Protocol Sponsor: Indiana University

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.

Who can join: Review the eligibility criteria below.

Location: Indiana University Health, University Hospital โ€” Indianapolis, Indiana

Age range: 12 Years to 55 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Indiana University Health, University Hospital โ€” Indianapolis, Indiana

๐Ÿ“ž Contact the Study Coordinator

Phone: (434) 466-0570

Email: emontase@iu.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Prediabetes clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—